Search

everythinglearnresearchcommunity

for

Search:↓

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Afatinib often causes skin problems that need proactive management.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

New therapies are being developed that target integrin pathways to treat various diseases.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Many patients on new leukemia drugs had mild to moderate skin reactions.

The compound 4c showed strong potential as an anticancer agent.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.